ImmunoGen's ovarian cancer drug fails in late-stage study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.

When compared with chemotherapy, the drug, mirvetuximab soravtansine, did not significantly prolong the duration that ovarian cancer patients survived without the disease progressing.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca's Lynparza meets main goal of late-stage cancer studyBritish drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Changi General Hospital found guilty of medical negligence in Stage IV cancer patientThe apex court found Changi General Hospital (CGH) guilty of negligence in a case where a delayed diagnosis caused the cancer of a terminal stage pat
Source: IndependentSG - 🏆 2. / 72 Read more »

Nearly half of children with cancer untreated: StudyPARIS (AFP) - Some 45 per cent of children with cancer are left undiagnosed and untreated, according to an innovative study of the disease's global footprint among under-15s, published Wednesday (Feb 27).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Radioactive cancer drugs could pose risk to cremation workers(Reuters Health) - Cancer patients often receive radioactive drugs that target tumor cells. A new case report suggests there could be ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Under one roof: S’pore Cancer Society, National Cancer Centre join forces to provide ‘holistic care’
Source: TODAYonline - 🏆 1. / 99 Read more »

National Cancer Centre Singapore teams up with Singapore Cancer Society to make genetic screening more accessibleSINGAPORE - The National Cancer Centre Singapore (NCCS) and the Singapore Cancer Society (SCS) have announced a partnership that aims to make cancer detection, prevention and treatment more accessible to patients who require financial aid.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »